ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Panacea Acquisition Corp

Panacea Acquisition Corp (NUVB)

2,45
0,04
(1,66%)
Fermé 06 Février 10:00PM
2,45
0,00
( 0,00% )
Avant marché: 1:00PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
2,45
Prix Achat
-
Prix Vente
-
Volume échangé
1
0,00 Fourchette du Jour 0,00
1,53 Plage de 52 semaines 4,1598
Cap du marché
Clôture Veille
2,45
Ouverture
-
Dernière Transaction
1
@
2.45
Dernière heure de transaction
12:53:05
Volume financier
-
VWAP
-
Volume moyen (3 m)
2 552 277
Actions en circulation
336 566 525
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-10,88
Bénéfice par action (BPA)
-0,23
Chiffre d'affairess
-
Bénéfice net
-75,8M

À propos de Panacea Acquisition Corp

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Panacea Acquisition Corp est coté dans le secteur Pharmaceutical Preparations de la New York Stock Exchange avec le ticker NUVB. Le dernier cours de clôture d'Panacea Acquisition était de US$2,45. Au cours de la dernière année, les actions de Panacea Acquisition ont été négociées dans une fourchette de prix de US$ 1,53 à US$ 4,1598.

Panacea Acquisition compte actuellement 336 566 525 actions en circulation. La capitalisation boursière d'Panacea Acquisition est de US$824,59 million. Panacea Acquisition a un ratio cours/bénéfice (ratio PE) de -10.88.

NUVB Dernières nouvelles

Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an Expanded Access Program (EAP) for...

Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, President, and Chief...

Nuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer

Taletrectinib will be marketed in China by Innovent Biologics Approval is based on the pivotal Phase 2 TRUST-I study, demonstrating taletrectinib's durable responses and prolonged...

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer

New Drug Application (NDA) is based on pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies of taletrectinib that demonstrated durable responses and prolonged progression-free...

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration PR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 20...

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

Nuvation Bio to Present at the Jefferies London Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.03-1.209677419352.482.542.22519522522.35154568CS
4-0.44-15.22491349482.892.992.22525124032.53384957CS
12-0.51-17.22972972972.963.4552.22525522772.71203528CS
26-0.73-22.95597484283.183.455220366192.69098645CS
520.958.0645161291.554.15981.5317767832.8276226CS
156-3.34-57.68566493965.796.050.9511398862.66286003CS
260-7.55-75.51015.230.9510760844.16023278CS

NUVB - Frequently Asked Questions (FAQ)

What is the current Panacea Acquisition share price?
The current share price of Panacea Acquisition is US$ 2,45
How many Panacea Acquisition shares are in issue?
Panacea Acquisition has 336 566 525 shares in issue
What is the market cap of Panacea Acquisition?
The market capitalisation of Panacea Acquisition is USD 824,59M
What is the 1 year trading range for Panacea Acquisition share price?
Panacea Acquisition has traded in the range of US$ 1,53 to US$ 4,1598 during the past year
What is the PE ratio of Panacea Acquisition?
The price to earnings ratio of Panacea Acquisition is -10,88
What is the reporting currency for Panacea Acquisition?
Panacea Acquisition reports financial results in USD
What is the latest annual profit for Panacea Acquisition?
The latest annual profit of Panacea Acquisition is USD -75,8M
What is the registered address of Panacea Acquisition?
The registered address for Panacea Acquisition is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Panacea Acquisition website address?
The website address for Panacea Acquisition is ecor1cap.com
Which industry sector does Panacea Acquisition operate in?
Panacea Acquisition operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NMTNuveen Massachusetts Quality Municipal Income Fund
US$ 18,58
(58,94%)
2
IVTInvenTrust Properties Corporation
US$ 41,99
(41,05%)
6
CNNECannae Holdings Inc
US$ 26,99
(37,63%)
6
JCENuveen Core Equity Alpha Fund
US$ 21,99
(37,35%)
7
CPSCooper Standard Holdings Inc
US$ 18,99
(28,48%)
83
NMINuveen Muni Income Fund Inc
US$ 5,01
(-49,29%)
1
DBLDoubleline Opportunities Credit Fund
US$ 10,01
(-36,87%)
51
STVNStevanato Group SpA
US$ 14,01
(-36,11%)
16
EMFTempleton Emerging Markets Fund Inc
US$ 8,00
(-35,28%)
4
PNIPIMCO NY Muni Income Fund
US$ 5,33
(-27,48%)
1
BBAIBigBear ai Holdings Inc
US$ 6,85
(-3,66%)
13,69M
FFord Motor Company
US$ 9,47
(-5,39%)
2,24M
SESSES AI Corporation
US$ 1,14
(2,70%)
1,04M
NIONIO Inc
US$ 4,245
(1,07%)
603,01k
QBTSD Wave Quantum Inc
US$ 6,44
(2,88%)
509,27k
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock